The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Kinetosis Drugs Market Research Report 2025
Synopsis
Kinetosis is a common problem in people traveling by car, train, airplanes, and especially boats. Motion sickness is a condition experienced by patient caused due to difference between the visually perceived motion and vestibular system’s senses of movement. Motion sickness is characterized by a set of symptoms such as nausea, fatigue, and dizziness.
The global Kinetosis Drugs market was valued at US$ 394 million in 2023 and is anticipated to reach US$ 482 million by 2030, witnessing a CAGR of 2.9% during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Kinetosis Drugs, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Kinetosis Drugs.
Report Scope
The Kinetosis Drugs market size, estimations, and forecasts are provided in terms of sales volume (Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Kinetosis Drugs market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Kinetosis Drugs manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
GlaxoSmithKline
Prestige Brands
WellSpring Pharmaceutical Corporation
Baxter International
Viatris
Sandoz
Pfizer
Myungmoon Pharm
Caleb Pharmaceuticals
Segment by Type
Anticholinergic
Antihistamines
Others
Segment by Application
Adults
Children
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Kinetosis Drugs manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Kinetosis Drugs in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Kinetosis is a common problem in people traveling by car, train, airplanes, and especially boats. Motion sickness is a condition experienced by patient caused due to difference between the visually perceived motion and vestibular system’s senses of movement. Motion sickness is characterized by a set of symptoms such as nausea, fatigue, and dizziness.
The global Kinetosis Drugs market was valued at US$ 394 million in 2023 and is anticipated to reach US$ 482 million by 2030, witnessing a CAGR of 2.9% during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Kinetosis Drugs, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Kinetosis Drugs.
Report Scope
The Kinetosis Drugs market size, estimations, and forecasts are provided in terms of sales volume (Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Kinetosis Drugs market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Kinetosis Drugs manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
GlaxoSmithKline
Prestige Brands
WellSpring Pharmaceutical Corporation
Baxter International
Viatris
Sandoz
Pfizer
Myungmoon Pharm
Caleb Pharmaceuticals
Segment by Type
Anticholinergic
Antihistamines
Others
Segment by Application
Adults
Children
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Kinetosis Drugs manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Kinetosis Drugs in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Index1 Kinetosis Drugs Market Overview
1.1 Product Overview and Scope of Kinetosis Drugs
1.2 Kinetosis Drugs Segment by Type
1.2.1 Global Kinetosis Drugs Market Value Comparison by Type (2024-2030)
1.2.2 Anticholinergic
1.2.3 Antihistamines
1.2.4 Others
1.3 Kinetosis Drugs Segment by Application
1.3.1 Global Kinetosis Drugs Market Value by Application: (2024-2030)
1.3.2 Adults
1.3.3 Children
1.4 Global Kinetosis Drugs Market Size Estimates and Forecasts
1.4.1 Global Kinetosis Drugs Revenue 2019-2030
1.4.2 Global Kinetosis Drugs Sales 2019-2030
1.4.3 Global Kinetosis Drugs Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Kinetosis Drugs Market Competition by Manufacturers
2.1 Global Kinetosis Drugs Sales Market Share by Manufacturers (2019-2024)
2.2 Global Kinetosis Drugs Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Kinetosis Drugs Average Price by Manufacturers (2019-2024)
2.4 Global Kinetosis Drugs Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Kinetosis Drugs, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Kinetosis Drugs, Product Type & Application
2.7 Kinetosis Drugs Market Competitive Situation and Trends
2.7.1 Kinetosis Drugs Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Kinetosis Drugs Players Market Share by Revenue
2.7.3 Global Kinetosis Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Kinetosis Drugs Retrospective Market Scenario by Region
3.1 Global Kinetosis Drugs Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Kinetosis Drugs Global Kinetosis Drugs Sales by Region: 2019-2030
3.2.1 Global Kinetosis Drugs Sales by Region: 2019-2024
3.2.2 Global Kinetosis Drugs Sales by Region: 2025-2030
3.3 Global Kinetosis Drugs Global Kinetosis Drugs Revenue by Region: 2019-2030
3.3.1 Global Kinetosis Drugs Revenue by Region: 2019-2024
3.3.2 Global Kinetosis Drugs Revenue by Region: 2025-2030
3.4 North America Kinetosis Drugs Market Facts & Figures by Country
3.4.1 North America Kinetosis Drugs Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Kinetosis Drugs Sales by Country (2019-2030)
3.4.3 North America Kinetosis Drugs Revenue by Country (2019-2030)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Kinetosis Drugs Market Facts & Figures by Country
3.5.1 Europe Kinetosis Drugs Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Kinetosis Drugs Sales by Country (2019-2030)
3.5.3 Europe Kinetosis Drugs Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Kinetosis Drugs Market Facts & Figures by Country
3.6.1 Asia Pacific Kinetosis Drugs Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Kinetosis Drugs Sales by Country (2019-2030)
3.6.3 Asia Pacific Kinetosis Drugs Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Kinetosis Drugs Market Facts & Figures by Country
3.7.1 Latin America Kinetosis Drugs Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Kinetosis Drugs Sales by Country (2019-2030)
3.7.3 Latin America Kinetosis Drugs Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Kinetosis Drugs Market Facts & Figures by Country
3.8.1 Middle East and Africa Kinetosis Drugs Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Kinetosis Drugs Sales by Country (2019-2030)
3.8.3 Middle East and Africa Kinetosis Drugs Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 U.A.E
4 Segment by Type
4.1 Global Kinetosis Drugs Sales by Type (2019-2030)
4.1.1 Global Kinetosis Drugs Sales by Type (2019-2024)
4.1.2 Global Kinetosis Drugs Sales by Type (2025-2030)
4.1.3 Global Kinetosis Drugs Sales Market Share by Type (2019-2030)
4.2 Global Kinetosis Drugs Revenue by Type (2019-2030)
4.2.1 Global Kinetosis Drugs Revenue by Type (2019-2024)
4.2.2 Global Kinetosis Drugs Revenue by Type (2025-2030)
4.2.3 Global Kinetosis Drugs Revenue Market Share by Type (2019-2030)
4.3 Global Kinetosis Drugs Price by Type (2019-2030)
5 Segment by Application
5.1 Global Kinetosis Drugs Sales by Application (2019-2030)
5.1.1 Global Kinetosis Drugs Sales by Application (2019-2024)
5.1.2 Global Kinetosis Drugs Sales by Application (2025-2030)
5.1.3 Global Kinetosis Drugs Sales Market Share by Application (2019-2030)
5.2 Global Kinetosis Drugs Revenue by Application (2019-2030)
5.2.1 Global Kinetosis Drugs Revenue by Application (2019-2024)
5.2.2 Global Kinetosis Drugs Revenue by Application (2025-2030)
5.2.3 Global Kinetosis Drugs Revenue Market Share by Application (2019-2030)
5.3 Global Kinetosis Drugs Price by Application (2019-2030)
6 Key Companies Profiled
6.1 GlaxoSmithKline
6.1.1 GlaxoSmithKline Corporation Information
6.1.2 GlaxoSmithKline Description and Business Overview
6.1.3 GlaxoSmithKline Kinetosis Drugs Sales, Revenue and Gross Margin (2019-2024)
6.1.4 GlaxoSmithKline Kinetosis Drugs Product Portfolio
6.1.5 GlaxoSmithKline Recent Developments/Updates
6.2 Prestige Brands
6.2.1 Prestige Brands Corporation Information
6.2.2 Prestige Brands Description and Business Overview
6.2.3 Prestige Brands Kinetosis Drugs Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Prestige Brands Kinetosis Drugs Product Portfolio
6.2.5 Prestige Brands Recent Developments/Updates
6.3 WellSpring Pharmaceutical Corporation
6.3.1 WellSpring Pharmaceutical Corporation Corporation Information
6.3.2 WellSpring Pharmaceutical Corporation Description and Business Overview
6.3.3 WellSpring Pharmaceutical Corporation Kinetosis Drugs Sales, Revenue and Gross Margin (2019-2024)
6.3.4 WellSpring Pharmaceutical Corporation Kinetosis Drugs Product Portfolio
6.3.5 WellSpring Pharmaceutical Corporation Recent Developments/Updates
6.4 Baxter International
6.4.1 Baxter International Corporation Information
6.4.2 Baxter International Description and Business Overview
6.4.3 Baxter International Kinetosis Drugs Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Baxter International Kinetosis Drugs Product Portfolio
6.4.5 Baxter International Recent Developments/Updates
6.5 Viatris
6.5.1 Viatris Corporation Information
6.5.2 Viatris Description and Business Overview
6.5.3 Viatris Kinetosis Drugs Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Viatris Kinetosis Drugs Product Portfolio
6.5.5 Viatris Recent Developments/Updates
6.6 Sandoz
6.6.1 Sandoz Corporation Information
6.6.2 Sandoz Description and Business Overview
6.6.3 Sandoz Kinetosis Drugs Sales, Revenue and Gross Margin (2019-2024)
6.6.4 Sandoz Kinetosis Drugs Product Portfolio
6.6.5 Sandoz Recent Developments/Updates
6.7 Pfizer
6.6.1 Pfizer Corporation Information
6.6.2 Pfizer Description and Business Overview
6.6.3 Pfizer Kinetosis Drugs Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Pfizer Kinetosis Drugs Product Portfolio
6.7.5 Pfizer Recent Developments/Updates
6.8 Myungmoon Pharm
6.8.1 Myungmoon Pharm Corporation Information
6.8.2 Myungmoon Pharm Description and Business Overview
6.8.3 Myungmoon Pharm Kinetosis Drugs Sales, Revenue and Gross Margin (2019-2024)
6.8.4 Myungmoon Pharm Kinetosis Drugs Product Portfolio
6.8.5 Myungmoon Pharm Recent Developments/Updates
6.9 Caleb Pharmaceuticals
6.9.1 Caleb Pharmaceuticals Corporation Information
6.9.2 Caleb Pharmaceuticals Description and Business Overview
6.9.3 Caleb Pharmaceuticals Kinetosis Drugs Sales, Revenue and Gross Margin (2019-2024)
6.9.4 Caleb Pharmaceuticals Kinetosis Drugs Product Portfolio
6.9.5 Caleb Pharmaceuticals Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Kinetosis Drugs Industry Chain Analysis
7.2 Kinetosis Drugs Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Kinetosis Drugs Production Mode & Process
7.4 Kinetosis Drugs Sales and Marketing
7.4.1 Kinetosis Drugs Sales Channels
7.4.2 Kinetosis Drugs Distributors
7.5 Kinetosis Drugs Customers
8 Kinetosis Drugs Market Dynamics
8.1 Kinetosis Drugs Industry Trends
8.2 Kinetosis Drugs Market Drivers
8.3 Kinetosis Drugs Market Challenges
8.4 Kinetosis Drugs Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
